HIMS
Hims & Hers Health, Inc. NYSE Listed Sep 13, 2019$25.66
Mkt Cap $5.6B
52w Low $13.74
21.0% of range
52w High $70.43
50d MA $22.74
200d MA $36.98
P/E (TTM)
48.1x
EV/EBITDA
52.1x
P/B
11.4x
Debt/Equity
2.3x
ROE
23.7%
P/FCF
98.8x
RSI (14)
—
ATR (14)
—
Beta
2.31
50d MA
$22.74
200d MA
$36.98
Avg Volume
39.8M
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
2269 Chestnut Street · San Francisco, CA 94123 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | AMC | 0.02 | 0.07 | +250.0% | 15.51 | -4.4% | -0.3% | +2.0% | +0.6% | -6.4% | +6.3% | — |
| Nov 3, 2025 | AMC | 0.09 | 0.06 | -33.3% | 44.39 | +3.1% | -3.6% | -1.5% | -6.5% | -7.6% | -7.5% | — |
| Aug 4, 2025 | AMC | 0.18 | 0.17 | -5.6% | 63.35 | -12.7% | -12.4% | -19.3% | -19.4% | -18.0% | -21.1% | — |
| May 5, 2025 | AMC | 0.12 | 0.20 | +65.4% | 41.88 | -8.5% | +18.1% | +25.0% | +22.7% | +24.1% | +31.8% | — |
| Feb 24, 2025 | AMC | 0.09 | 0.11 | +22.2% | 51.31 | -22.3% | -22.3% | -18.4% | -19.4% | -12.1% | -20.7% | — |
| Nov 4, 2024 | AMC | 0.06 | 0.06 | +0.0% | 20.76 | +6.4% | -0.6% | +12.8% | +13.8% | +12.8% | +34.3% | — |
| Aug 5, 2024 | AMC | 0.04 | 0.06 | +40.5% | 17.84 | -1.8% | -5.4% | -10.1% | -11.2% | -10.5% | -10.5% | — |
| May 6, 2024 | AMC | 0.01 | 0.05 | +316.7% | 11.65 | +17.1% | +6.0% | +4.3% | +10.9% | +5.5% | +10.6% | — |
| Feb 26, 2024 | AMC | 0.00 | 0.01 | +151.9% | 10.25 | +20.3% | +31.0% | +30.0% | +27.2% | +28.0% | +43.4% | — |
| Nov 6, 2023 | AMC | -0.03 | -0.04 | -27.4% | 6.28 | +7.8% | +11.0% | +11.8% | +5.6% | +8.4% | +11.5% | — |
| Aug 7, 2023 | AMC | -0.05 | -0.03 | +40.0% | 7.90 | +17.2% | -5.8% | -7.3% | -9.0% | -8.9% | -9.9% | — |
| May 8, 2023 | AMC | -0.07 | -0.05 | +28.6% | 11.85 | -9.1% | -10.1% | -9.7% | -10.8% | -8.8% | -9.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 24 | JP Morgan | Initiates | Overweight | $35 | $28.15 | $29.50 | +4.8% | +8.6% | +4.4% | -0.9% | -6.5% | -3.5% |
| Apr 24 | BofA Securities | Maintains | Neutral → Neutral | — | $28.15 | $29.50 | +4.8% | +8.6% | +4.4% | -0.9% | -6.5% | -3.5% |
| Apr 16 | BofA Securities | Maintains | Neutral → Neutral | — | $24.29 | $26.15 | +7.7% | +11.1% | +18.6% | +27.7% | +22.5% | +19.4% |
| Mar 27 | TD Cowen | Maintains | Hold → Hold | — | $20.86 | $20.58 | -1.3% | -7.1% | -10.0% | -0.5% | -4.9% | -8.2% |
| Mar 16 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $24.77 | $24.22 | -2.2% | +0.4% | +0.8% | -6.5% | -2.5% | -11.1% |
| Mar 11 | Barclays | Maintains | Overweight → Overweight | — | $23.47 | $23.12 | -1.5% | +10.3% | +1.6% | +5.5% | +6.0% | +6.4% |
| Mar 10 | Deutsche Bank | Maintains | Hold → Hold | — | $22.16 | $24.00 | +8.3% | +5.9% | +16.8% | +7.6% | +11.8% | +12.3% |
| Mar 10 | Citigroup | Upgrade | Sell → Neutral | — | $22.16 | $24.00 | +8.3% | +5.9% | +16.8% | +7.6% | +11.8% | +12.3% |
| Mar 10 | BofA Securities | Upgrade | Underperform → Neutral | — | $22.16 | $24.00 | +8.3% | +5.9% | +16.8% | +7.6% | +11.8% | +12.3% |
| Mar 9 | Needham | Upgrade | Hold → Buy | — | $15.74 | $23.22 | +47.5% | +40.8% | +49.1% | +64.4% | +51.5% | +57.4% |
| Feb 25 | Barclays | Maintains | Overweight → Overweight | — | $15.46 | $15.67 | +1.4% | +2.3% | +0.9% | -6.1% | +6.6% | +2.3% |
| Feb 25 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $15.46 | $15.67 | +1.4% | +2.3% | +0.9% | -6.1% | +6.6% | +2.3% |
| Feb 24 | Truist | Maintains | Hold → Hold | — | $15.51 | $14.83 | -4.4% | -0.3% | +2.0% | +0.6% | -6.4% | +6.3% |
| Feb 24 | TD Cowen | Maintains | Hold → Hold | — | $15.51 | $14.83 | -4.4% | -0.3% | +2.0% | +0.6% | -6.4% | +6.3% |
| Feb 24 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $15.51 | $14.83 | -4.4% | -0.3% | +2.0% | +0.6% | -6.4% | +6.3% |
| Feb 24 | Evercore ISI | Maintains | In Line → In Line | — | $15.51 | $14.83 | -4.4% | -0.3% | +2.0% | +0.6% | -6.4% | +6.3% |
| Feb 24 | Citigroup | Maintains | Sell → Sell | — | $15.51 | $14.83 | -4.4% | -0.3% | +2.0% | +0.6% | -6.4% | +6.3% |
| Feb 24 | BTIG | Downgrade | Buy → Neutral | — | $15.51 | $14.83 | -4.4% | -0.3% | +2.0% | +0.6% | -6.4% | +6.3% |
| Feb 9 | TD Cowen | Maintains | Hold → Hold | — | $23.02 | $17.83 | -22.5% | -16.0% | -25.1% | -27.5% | -31.4% | -29.2% |
| Feb 9 | Citigroup | Maintains | Sell → Sell | — | $23.02 | $17.83 | -22.5% | -16.0% | -25.1% | -27.5% | -31.4% | -29.2% |
| Feb 9 | BofA Securities | Maintains | Underperform → Underperform | — | $23.02 | $17.83 | -22.5% | -16.0% | -25.1% | -27.5% | -31.4% | -29.2% |
| Feb 2 | BTIG | Maintains | Buy → Buy | — | $27.09 | $27.11 | +0.1% | -2.4% | -5.7% | -9.9% | -13.3% | -15.0% |
| Nov 4 | BofA Securities | Maintains | Underperform → Underperform | — | $44.39 | $45.75 | +3.1% | -3.6% | -1.5% | -6.5% | -7.6% | -7.5% |
| Nov 4 | BTIG | Maintains | Buy → Buy | — | $44.39 | $45.75 | +3.1% | -3.6% | -1.5% | -6.5% | -7.6% | -7.5% |
| Sep 12 | Canaccord Genuity | Maintains | Buy → Buy | — | $51.76 | $51.03 | -1.4% | +7.2% | +4.3% | -1.7% | -2.7% | +8.6% |
| Aug 18 | Truist | Maintains | Hold → Hold | — | $46.02 | $45.22 | -1.7% | -2.0% | -8.3% | -5.7% | -4.5% | -3.2% |
| Aug 5 | Needham | Maintains | Hold → Hold | — | $63.35 | $55.30 | -12.7% | -12.4% | -19.3% | -19.4% | -18.0% | -21.1% |
| Jul 17 | Truist | Maintains | Hold → Hold | — | $51.85 | $51.72 | -0.3% | -3.6% | -2.8% | -8.2% | -3.5% | +11.9% |
| Jun 11 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $55.25 | $54.68 | -1.0% | +4.2% | +3.4% | +0.4% | +8.2% | +7.2% |
| Jun 4 | Needham | Maintains | Buy → Buy | — | $54.73 | $55.77 | +1.9% | -2.0% | -3.6% | +2.9% | +3.9% | +1.0% |
| May 6 | Piper Sandler | Maintains | Neutral → Neutral | — | $41.88 | $38.33 | -8.5% | +18.1% | +25.0% | +22.7% | +24.1% | +31.8% |
| May 6 | Citigroup | Maintains | Sell → Sell | — | $41.88 | $38.33 | -8.5% | +18.1% | +25.0% | +22.7% | +24.1% | +31.8% |
| May 6 | Needham | Maintains | Buy → Buy | — | $41.88 | $38.33 | -8.5% | +18.1% | +25.0% | +22.7% | +24.1% | +31.8% |
| Apr 29 | BofA Securities | Maintains | Underperform → Underperform | — | $28.48 | $37.94 | +33.2% | +23.0% | +16.2% | +27.0% | +43.3% | +47.1% |
| Apr 29 | TD Cowen | Downgrade | Buy → Hold | — | $28.48 | $37.94 | +33.2% | +23.0% | +16.2% | +27.0% | +43.3% | +47.1% |
| Apr 29 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $28.48 | $37.94 | +33.2% | +23.0% | +16.2% | +27.0% | +43.3% | +47.1% |
| Apr 25 | Citigroup | Maintains | Sell → Sell | — | $28.14 | $27.86 | -1.0% | -0.2% | +1.2% | +24.5% | +17.6% | +28.5% |
| Apr 10 | Truist | Maintains | Hold → Hold | — | $29.49 | $28.49 | -3.4% | -9.1% | -7.7% | -4.0% | -0.1% | -8.6% |
| Mar 18 | BofA Securities | Maintains | Underperform → Underperform | — | $34.69 | $34.31 | -1.1% | -9.2% | -2.3% | -5.2% | +0.2% | +7.8% |
| Mar 6 | Citigroup | Maintains | Sell → Sell | — | $40.89 | $37.40 | -8.5% | -15.9% | -12.1% | -15.7% | -15.1% | -17.0% |
| Mar 6 | BofA Securities | Maintains | Underperform → Underperform | — | $40.89 | $37.40 | -8.5% | -15.9% | -12.1% | -15.7% | -15.1% | -17.0% |
| Feb 26 | Truist | Maintains | Hold → Hold | — | $39.86 | $40.24 | +1.0% | +5.1% | +3.7% | +13.1% | +2.1% | +1.6% |
| Feb 25 | Piper Sandler | Maintains | Neutral → Neutral | — | $51.31 | $39.88 | -22.3% | -22.3% | -18.4% | -19.4% | -12.1% | -20.7% |
| Feb 25 | Citigroup | Maintains | Sell → Sell | — | $51.31 | $39.88 | -22.3% | -22.3% | -18.4% | -19.4% | -12.1% | -20.7% |
| Feb 25 | Needham | Maintains | Buy → Buy | — | $51.31 | $39.88 | -22.3% | -22.3% | -18.4% | -19.4% | -12.1% | -20.7% |
| Feb 25 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $51.31 | $39.88 | -22.3% | -22.3% | -18.4% | -19.4% | -12.1% | -20.7% |
| Feb 20 | BofA Securities | Maintains | Underperform → Underperform | — | $68.74 | $65.08 | -5.3% | -3.4% | -28.3% | -25.4% | -42.0% | -39.1% |
| Feb 19 | Canaccord Genuity | Maintains | Buy → Buy | — | $58.50 | $59.26 | +1.3% | +17.5% | +13.5% | -15.8% | -12.3% | -31.9% |
| Feb 18 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $60.47 | $60.70 | +0.4% | -3.3% | +13.7% | +9.8% | -18.5% | -15.1% |
| Jan 10 | Citigroup | Downgrade | Neutral → Sell | — | $25.73 | $24.15 | -6.1% | -1.2% | +0.7% | +1.9% | +8.3% | +8.6% |
No insider trades available.
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Hims secured a strategic Novo Nordisk partnership to expand GLP-1 weight-loss offerings, positioning it competitively in the booming telehealth obesity market and diversifying beyond single-drug dependency.
Mar 11
8-K
Hims & Hers Health, Inc. -- 8-K Filing
Hims & Hers reported fourth quarter and full year 2025 financial results, with CFO Oluyemi Okupe as principal financial officer; detailed results available in shareholder letter.
Feb 23
8-K · 1.01
!! High
Hims & Hers Health, Inc. -- 8-K 1.01: Material Agreement
Hims & Hers is expanding internationally through a strategic acquisition of an Australia-based digital health operator with established presence in five countries, strengthening its global telehealth footprint.
Feb 19
Data updated apr 25, 2026 1:28pm
· Source: massive.com